The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Disclaimer
This presentation paper is provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The paper is not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation paper should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
Presentation
- Presented by: Jeff Wan and Paul Stephney
- Presented at: Online
- Presentation date: 13 May 2021
- Presentation summary: Recent legislative and regulatory changes for listed medicine manufacturers and an overview of common issues identified during GMP inspections of listed medicine manufacturers
Webinar presentation: How to improve your GMP Compliance for Listed Medicines and GMP implementation of TGOs 92 and 101 (pdf,1968kb)